stage 2 meaningful use: issues and strategies€¦ · meaningful use 1 at a glance •...

HBMA 2012 – Fall Conference

September 12-14, 2012

© Sterling Solutions, 2012 1

Stage 2 Meaningful Use:Stage 2 Meaningful Use:Issues and StrategiesIssues and Strategies

HBMAHBMA Presented byPresented byRon SterlingRon Sterling

Sterling Solutions, Ltd.Sterling Solutions, Ltd.301301--681681--4247 4247

AvoidAvoid--EHREHR--Disasters.comDisasters.comrbsterling@[email protected]

www.sterlingwww.sterling--solutions.comsolutions.com

HBMAHBMAFall ConferenceFall ConferenceSeptember 12September 12--14, 201214, 2012

National Harbor, MDNational Harbor, MD

©2012 Sterling Solutions, Ltd. 1

Meaningful Use GoalsMeaningful Use Goals•• Engage Patients and FamiliesEngage Patients and Families

-- Provide Access to DataProvide Access to DataT l t S t I f d D i iT l t S t I f d D i i-- Tools to Support Informed DecisionsTools to Support Informed Decisions

•• Improve Care CoordinationImprove Care Coordination-- Exchange Data with Other ProvidersExchange Data with Other Providers

•• Improve Population and Public HealthImprove Population and Public Health-- Communicate with Public AgenciesCommunicate with Public Agencies

E P i d S itE P i d S it

©2012 Sterling Solutions, Ltd.

•• Ensure Privacy and SecurityEnsure Privacy and Security-- Data TransparencyData Transparency-- Supporting Policies, Procedures, and TechnologySupporting Policies, Procedures, and Technology

2




Meaningful Use IssuesMeaningful Use Issues


•• Stage 1 MU Measures OnlyStage 1 MU Measures Only-- Significant Missing PiecesSignificant Missing Pieces

WorkflowWorkflow

Certified EHR LimitationsCertified EHR Limitations

Patient ServicePatient ServiceCharting (Stage 2)Charting (Stage 2)Imaging (Stage 2)Imaging (Stage 2)

•• Stage 2 EHR CertificationStage 2 EHR Certification•• Vendor ResponseVendor Response


•• Time to ImplementTime to Implement




Certified EHR LimitationsCertified EHR Limitations•• EHR Measuring MUEHR Measuring MU

-- Data Driven orData Driven or-- ChecklistsChecklistsChecklistsChecklists

•• EHR Design IssuesEHR Design Issues-- Targeted Practice/HCO SizeTargeted Practice/HCO Size-- Duplicate EntryDuplicate Entry-- ModularizationModularization


•• Some EHR Support Selected CQMsSome EHR Support Selected CQMs

MU Strategic IssuesMU Strategic Issues

•• Eligible Provider vs. HCO FocusEligible Provider vs. HCO Focus

•• Critical Path for MUCritical Path for MU

•• Provider and HCO DisruptionsProvider and HCO Disruptions

•• Patient ConfusionPatient Confusion


•• Split EPsSplit EPs

•• Family MembersFamily Members




Tactical IssuesTactical Issues•• Rollout StrategyRollout Strategy

-- Selecting EPSelecting EP-- MU Critical Path and EHR StagesMU Critical Path and EHR StagesMU Critical Path and EHR StagesMU Critical Path and EHR Stages

•• Patients Served by Multiple Eligible ProvidersPatients Served by Multiple Eligible Providers•• Structured vs. Unstructured InformationStructured vs. Unstructured Information•• Supporting MU Among “Selected Patients”Supporting MU Among “Selected Patients”

-- Selection Strategy and CriteriaSelection Strategy and Criteria


-- Clinical Care Issues and ExposureClinical Care Issues and Exposure•• Dealing with “Other Patients”Dealing with “Other Patients”

•• Critical Path of EHR and MU ImplementationCritical Path of EHR and MU Implementation

MU Related Medical MU Related Medical Professional Liability ExposureProfessional Liability Exposure

pp•• WorkaroundsWorkarounds•• Confusion Among Providers and PatientsConfusion Among Providers and Patients

•• Selection of MU Menu OptionsSelection of MU Menu Options•• Attaining and Holding MU MeasuresAttaining and Holding MU Measures


g gg g•• Implied Standards of CareImplied Standards of Care•• Selected MU/EHR PatientsSelected MU/EHR Patients




•• 90 Day Reporting Period for First 90 Day Reporting Period for First Payment YearPayment Year

Calendar IssuesCalendar Issues

Payment YearPayment Year

•• 90 Day Reporting Period for Stage 2 90 Day Reporting Period for Stage 2 in 2014in 2014


MU as Part of EHR Utili ationMU as Part of EHR Utili ationMU as Part of EHR Utilization MU as Part of EHR Utilization GoalsGoals





Setting Goals to Measure ResultsSetting Goals to Measure Results•• GoalsGoals

•• Select MeasuresSelect MeasuresPP I l t ti M tI l t ti M t•• PrePre--Implementation MeasurementImplementation Measurement

•• Interim Measurement/ToleranceInterim Measurement/Tolerance•• Frequency of MeasurementFrequency of Measurement•• Performance Level to Go ForwardPerformance Level to Go Forward•• Reasons to DelayReasons to Delay


Reasons to DelayReasons to Delay•• Remediation StrategyRemediation Strategy•• Fix Previous Installation(s)Fix Previous Installation(s)

What Will You Measure?What Will You Measure?Patient FlowPatient FlowPhysician ProductivityPhysician ProductivityDecrease in EHR Transition SupportDecrease in EHR Transition Support•• TrainingTraining•• MentoringMentoring•• ScribesScribes


Staff ProductivityStaff ProductivityMU MeasuresMU Measures

12




Goal Attainment StepsGoal Attainment Steps•• Plan for UsePlan for Use

-- Practice Rollout StepsPractice Rollout Steps-- MU AttainmentMU Attainment

•• Go/NoGo Decision PointsGo/NoGo Decision Points-- Initial UseInitial Use-- Expand Use for Initial Expand Use for Initial

ProviderProvider


o deo de-- Expand to Other DoctorsExpand to Other Doctors-- Expand to Other Expand to Other

Offices/LocationsOffices/Locations

Meaningful Use Stage 1Meaningful Use Stage 1





MU Stage 1 MU Stage 1 -- 20112011

•• Eligible Providers (EP)Eligible Providers (EP)15 MU Core Measures15 MU Core Measures-- 15 MU Core Measures15 MU Core Measures

-- 5 of 10 Menu Set Measures5 of 10 Menu Set Measures

•• Electronic Submission 2012 OnwardElectronic Submission 2012 Onward


Meaningful Use 1 at A GlanceMeaningful Use 1 at A Glance•• CollectCollect

-- Demographics Demographics –– Language, Gender, Race, DOB, Ethnicity Language, Gender, Race, DOB, Ethnicity (Date/Cause of Death for EH)(Date/Cause of Death for EH)(Date/Cause of Death for EH)(Date/Cause of Death for EH)

-- Diagnoses, Medications, Vitals, AllergiesDiagnoses, Medications, Vitals, Allergies-- Smoking StatusSmoking Status-- Prescriptions and DURPrescriptions and DUR

•• ShareShare-- Electronic Prescriptions (EP Only)Electronic Prescriptions (EP Only)


p ( y)p ( y)-- Provide Patient Electronic Copy of Provide Patient Electronic Copy of

Patient Health InformationPatient Health InformationDischarge InstructionsDischarge InstructionsClinical SummaryClinical Summary

-- (Test) Exchange of Clinical Information(Test) Exchange of Clinical Information16




Meaningful Use 1 at A GlanceMeaningful Use 1 at A Glance

•• SupportSupport-- Protect and Secure PHIProtect and Secure PHI-- Use One Clinical Decision Support RuleUse One Clinical Decision Support Rule-- Report Clinical Quality Measures (CQM)Report Clinical Quality Measures (CQM)

-- Changes in Stage 2Changes in Stage 2


EP CQM RequirementsEP CQM Requirements-- 3 Core CQMs (with 3 Alternates)3 Core CQMs (with 3 Alternates)

-- NQF0013 NQF0013 –– Hypertension BPHypertension BP-- NQF0028 NQF0028 –– Tobacco Preventive CareTobacco Preventive Care-- NQF0421 NQF0421 –– Adult Weight ScreeningAdult Weight Screening

-- 3 Alternative Core CQMs3 Alternative Core CQMs-- NQF0024 NQF0024 –– Child Weight AssessmentChild Weight Assessment


-- NQF0041 NQF0041 –– Influenza ImmunizationInfluenza Immunization-- NQF0038 NQF0038 –– Childhood ImmunizationChildhood Immunization

-- Plus 3 Other CQMsPlus 3 Other CQMs




Meaningful Use 1 Menu OptionsMeaningful Use 1 Menu Options•• CollectCollect

-- Lab Information as Structured Data (Stage 2 Core)Lab Information as Structured Data (Stage 2 Core)-- ADR (EH)ADR (EH)

•• ManageManagegg-- Drug Formulary CheckDrug Formulary Check-- Preventive FollowPreventive Follow--Up Reminders to Patients (EP) (Stage 2 Core)Up Reminders to Patients (EP) (Stage 2 Core)-- Medication Reconciliation (Stage 2 Core)Medication Reconciliation (Stage 2 Core)

•• ShareShare-- Patient Access to Health Information (EP)Patient Access to Health Information (EP)-- Provide Patient Education ResourcesProvide Patient Education Resources

Provide Summary of Care to Another ProviderProvide Summary of Care to Another Provider


-- Provide Summary of Care to Another ProviderProvide Summary of Care to Another Provider-- Electronic Lab Reports to Public Health Agencies (EH) Electronic Lab Reports to Public Health Agencies (EH)

•• ReportReport-- One Report of Patients by ConditionOne Report of Patients by Condition-- Test Immunization Registry SubmissionTest Immunization Registry Submission-- Test Submission of Syndromic Surveillance Data to PHATest Submission of Syndromic Surveillance Data to PHA

19

General ConceptsGeneral Concepts•• Unique Patients in Reporting PeriodUnique Patients in Reporting Period

•• Must Indicate None if Applicable to CountMust Indicate None if Applicable to CountMust Indicate None if Applicable to CountMust Indicate None if Applicable to Count

•• After Initial Entry, Use Clinical JudgmentAfter Initial Entry, Use Clinical Judgment

•• EP Excluded from Meeting NonEP Excluded from Meeting Non--Applicable Applicable Measures Measures





MU NotesMU Notes•• Medicare EP Without Attaining MU by Medicare EP Without Attaining MU by

2015 Subject to Payment 2015 Subject to Payment AdjustmentsAdjustmentsAdjustmentsAdjustments

•• No Medicaid Based Payment No Medicaid Based Payment AdjustmentsAdjustments


Navigating Stage 1 MUNavigating Stage 1 MU





Stage 1 MU OverviewStage 1 MU Overview

CPOEC-1-30% UP

Clinical Summary

C-13-50% OV


Report andDistribute

Protect Electronic Health Info

C-15

23

Med AllergyC-6-80% UP

Reconcile MedsM-7-50%

Trans of Care

Stage 1 CPOEStage 1 CPOE

Active MedsC-5-80% UP

Drug/DrugDrug/Allergy

CheckC-2

DrugFormulary

M-1


CPOEC-1-30% UP

eRxC-4

DemographicsC-7-50% UP

24




Measure SpecificsMeasure Specifics•• Demographics (CDemographics (C--77--50%) 50%)

-- Preferred LanguagePreferred Language-- GenderGender-- GenderGender-- RaceRace-- EthnicityEthnicity-- Date of BirthDate of Birth

•• Vitals (CVitals (C--88--50%)50%)-- HeightHeight


HeightHeight-- WeightWeight-- BPBP-- BMIBMI-- Growth ChartsGrowth Charts

Stage 1 Clinical SummariesStage 1 Clinical Summaries

Problem ListC-3-80% UP

Vital Signs> 2

C-8-50% UP

Smoking Status > 13C-9-50% UP One Clinical

Decision

CPOEC-1-30% UP

w/Rx Clinical Summary

C-13-50% OV

Lab Test ResultsM-2-40%

Labs

Support RuleC-11


Pat SpecificEdu Resources

M-6-10% UP

26




Clinical Summaries (CClinical Summaries (C--1313--50%)50%)•• Updated Medication List (CUpdated Medication List (C--11--30%, and C30%, and C--55--80%)80%)•• Updated Vitals (CUpdated Vitals (C--88--50%)50%)•• Updated Problem List (CUpdated Problem List (C--33--80%)80%)•• ImmunizationsImmunizationsImmunizationsImmunizations•• Medications AdministeredMedications Administered•• Reason for VisitReason for Visit•• ProceduresProcedures•• InstructionsInstructions•• Summary of TopicsSummary of Topics

N t A i t t/T tN t A i t t/T t


•• Next Appointment/TestNext Appointment/Test•• Other Appointments/Test with ContactsOther Appointments/Test with Contacts•• Test Orders and Results (MTest Orders and Results (M--22--40%)40%)•• Decision Aids (CDecision Aids (C--11)11)•• SymptomsSymptoms

27

Patient Reminders

M-4-20%ALL Patients

Exchange Clinical Info

C-14 – Test(S2 – Not Req.)

Clinical Summary

C-13-50% OV

Stage 1 Report and DistributeStage 1 Report and Distribute

Clinical Quality

Patient ListsM-3-One Report

Elect Copy of Health Info

C-12-50% Requests

PatientElect Access

M-5-10% UP


yMeasures

C-10

Syndromic Surveillance

DataM-10-Test

Immunization RegistryM-9-Test

Transition of Care Summary

M-8-50% Transitions

Requests

28




Measure SpecificsMeasure Specifics•• Electronic Copy of EP Health Information (CElectronic Copy of EP Health Information (C--1212--50%) of 50%) of

Requests Within 3 Business Days)Requests Within 3 Business Days)•• Diagnostic Test ResultsDiagnostic Test Results•• Problem ListsProblem Lists•• Medication ListsMedication Lists•• Medication AllergiesMedication Allergies•• Discharge Summary and Procedures for EHDischarge Summary and Procedures for EH

•• Electronic Exchange of Clinical Information (CElectronic Exchange of Clinical Information (C--1414--Test)Test)•• Problem ListProblem List•• Medication ListMedication List


•• Medication AllergiesMedication Allergies•• Diagnostic Test ResultsDiagnostic Test Results

29

Statistical DilemmasStatistical Dilemmas•• Requirements for Clinical Summaries (50% Requirements for Clinical Summaries (50%

of OV)of OV)-- CPOE (30% of Unique Patients)CPOE (30% of Unique Patients)

-- Lab Test Results (40% of Lab Tests)Lab Test Results (40% of Lab Tests)

•• How Useful are Reports and Distributions How Useful are Reports and Distributions that Only Represent 50% of Office Visits?that Only Represent 50% of Office Visits?


that Only Represent 50% of Office Visits?that Only Represent 50% of Office Visits?

•• What Do You Have to Do for the Other 50% What Do You Have to Do for the Other 50% of Office Visits?of Office Visits?




Security Risk AssessmentSecurity Risk Assessment



EvaluateEvaluate•• AdministrativeAdministrative•• PhysicalPhysical•• TechnologyTechnology

IdentifyIdentify•• ThreatsThreats


•• ThreatsThreats•• WeaknessesWeaknesses

32





AnalyzeAnalyze•• ControlsControls•• PossibilityPossibility•• ImpactImpact

Itemize RecommendationsItemize Recommendations•• Scope MitigationScope Mitigation


•• Scope MitigationScope Mitigation•• Check ImplementationCheck Implementation•• Verify ComplianceVerify Compliance

33

Final Meaningful Use Stage 2Final Meaningful Use Stage 2





Final MU Stage 2 Final MU Stage 2 -- 20142014•• 17 Core Measures17 Core Measures•• 3 of 5 Menu Measures3 of 5 Menu Measures•• Measure ChangesMeasure Changes•• Measure Changes Measure Changes

-- Tighter TimeframesTighter Timeframes-- Higher PercentageHigher Percentage-- Apply to All PatientsApply to All Patients-- Test to Limited ProductionTest to Limited Production

M i M t CM i M t C


-- Moving Menu to CoreMoving Menu to Core•• CQM Part of PQRSCQM Part of PQRS•• More Patient InteractionsMore Patient Interactions

-- Online Messaging (EP)Online Messaging (EP)

Final MU Stage 2 Final MU Stage 2 -- 20142014•• CollectCollect

-- Demographics Demographics –– Language, Gender, Race, DOB, EthnicityLanguage, Gender, Race, DOB, Ethnicity-- Medication Reconciliation (Stage 1 Menu)Medication Reconciliation (Stage 1 Menu)-- Medication Reconciliation (Stage 1 Menu)Medication Reconciliation (Stage 1 Menu)-- VitalsVitals-- Smoking StatusSmoking Status-- Computerized Patient Orders For PrescriptionsComputerized Patient Orders For Prescriptions, , Labs, and Labs, and

Radiology Orders (NEW)Radiology Orders (NEW)-- Incorporate Lab Test Results (Stage 1 Menu)Incorporate Lab Test Results (Stage 1 Menu)

Images (MENU) (NEW)Images (MENU) (NEW)


-- Images (MENU) (NEW)Images (MENU) (NEW)-- Discrete Family Health History (MENU) (NEW)Discrete Family Health History (MENU) (NEW)-- Electronic Note (MENU) (NEW)Electronic Note (MENU) (NEW)

36




Final MU Stage 2 Final MU Stage 2 -- 20142014•• ShareShare

-- Use Secure Messaging With Patients (NEW)Use Secure Messaging With Patients (NEW)-- Provide Patient Specific Education (Stage 1 Menu)Provide Patient Specific Education (Stage 1 Menu)-- Provide Patient Specific Education (Stage 1 Menu)Provide Patient Specific Education (Stage 1 Menu)-- Electronic Prescriptions (EP Only)Electronic Prescriptions (EP Only)-- Online Access to Health Information (Stage 1 Menu)Online Access to Health Information (Stage 1 Menu)-- Provide Copy of Clinical SummaryProvide Copy of Clinical Summary-- Transition of Care Summary (Stage 1 Menu)Transition of Care Summary (Stage 1 Menu)-- Submit Immunization Registries (Stage 1 Menu)Submit Immunization Registries (Stage 1 Menu)

S b i S d i S ill D (MENU)S b i S d i S ill D (MENU)


-- Submit Syndromic Surveillance Data (MENU)Submit Syndromic Surveillance Data (MENU)-- Cancer Case Reporting (MENU)Cancer Case Reporting (MENU)-- NonNon--Cancer Case Reporting (MENU)Cancer Case Reporting (MENU)

37

Final Stage 2Final Stage 2

•• SupportSupport-- Generate One Report of Patients with a Generate One Report of Patients with a pp

Specific Condition (Stage 1 Menu)Specific Condition (Stage 1 Menu)-- Generate Reminders (Stage 1 Menu)Generate Reminders (Stage 1 Menu)-- Protect and Secure PHIProtect and Secure PHI-- Use Use FiveFive Clinical Decision Support RulesClinical Decision Support Rules





Clinical Quality Measures (CQM)Clinical Quality Measures (CQM)Submit CQM data electronicallySubmit CQM data electronicallyEPs will submit 9 CQMs from at least 3 of the EPs will submit 9 CQMs from at least 3 of the National Quality StrategyNational Quality Strategy•• From 64 CQMs across 6 domains From 64 CQMs across 6 domains •• From 64 CQMs across 6 domains. From 64 CQMs across 6 domains.

Physician Quality Reporting System (PQRS) Physician Quality Reporting System (PQRS) Reporting will credit the PQRS and Medicare EHR Reporting will credit the PQRS and Medicare EHR Incentive ProgramsIncentive Programs


Navigating Stage 2 MUNavigating Stage 2 MU





Stage 2 MU OverviewStage 2 MU OverviewCPOE

C-Rx (60%),Lab (30%), Rad (30%) Orders

Clinical SummaryC-50% OVw/I 24 Hrs


Report andDistribute

SecurityRisk

AnalysisC

41

Drug/DrugReconcile Meds

C-50%Trans of Care

Stage 2 CPOEStage 2 CPOE

Drug/AllergyCheck

C - Clinical Decision

Trans of Care

eRxC- 50% Rx

w/ 1+ Formularies

CPOEC-Rx (60%),

Lab (30%) Rad


DemographicsC-80% UP

42

Lab (30%), Rad (30%) Orders




Measure SpecificsMeasure Specifics•• Demographics (CDemographics (C--80%) 80%)

-- Preferred LanguagePreferred Language-- GenderGender-- GenderGender-- RaceRace-- EthnicityEthnicity-- Date of BirthDate of Birth

•• Vitals (CVitals (C--80%)80%)-- HeightHeight


HeightHeight-- WeightWeight-- BPBP-- BMIBMI-- Growth ChartsGrowth Charts

Stage 2 Clinical SummariesStage 2 Clinical SummariesVital SignsC-80% UP

Smoking Status > 13

C-80% UPFive Clinical

Decision Support RulesAlso Drug Drug/

ImagingM- 10% Scans

and Tests

Lab Test ResultsC-55%Labs

Also Drug-Drug/Drug-Allergy

C

Clinical SummaryC-50% OVw/I 24 Hrs

CPOEC-Rx (60%),

Lab (30%), Rad (30%) Orders


Pat SpecificEdu Resources

C-10% UP

44

Discrete Patient Family

HistoryM-20% UP Electronic

NoteM- 30% UP




Clinical Summaries (CClinical Summaries (C--50%)50%)•• Updated Medication List Updated Medication List •• Updated Vitals (CUpdated Vitals (C--80%)80%)•• Updated Problem ListUpdated Problem List•• ImmunizationsImmunizationsImmunizationsImmunizations•• Medications AdministeredMedications Administered•• Reason for VisitReason for Visit•• ProceduresProcedures•• InstructionsInstructions•• Summary of TopicsSummary of Topics

N t A i t t/T tN t A i t t/T t


•• Next Appointment/TestNext Appointment/Test•• Other Appointments/Test with ContactsOther Appointments/Test with Contacts•• Test Orders and Results (C)Test Orders and Results (C)•• Decision Aids (C)Decision Aids (C)•• SymptomsSymptoms

45

Patient Reminders

C-10%ALL Patients

w/I 24 mo

Online Access to Health Info

w/i 4 DaysC-50% UP

5%UP Access/ DL/Transmit

Stage 2 Report and DistributeStage 2 Report and DistributeClinical

SummaryC-50% OVw/I 24 Hrs

Cancer Registry

Patient ListsC-One Report

Transition of Care Summary

C 50%

Secure Messaging

C-5% UP


eg st yReportingM - Ongoing

Syndromic Surveillance

DataM-Ongoing

Immunization Registry

C - Ongoing

C-50% 10% Electronic

Transitions

46

Specialized Registry

ReportingM - Ongoing




MU Action PlanMU Action Plan•• Analyze MU Critical Path IssuesAnalyze MU Critical Path Issues•• Plan EHR and MU DeploymentPlan EHR and MU Deployment

D i MU d EHR I l t tiD i MU d EHR I l t ti•• Design MU and EHR ImplementationDesign MU and EHR Implementation•• Measure and MonitorMeasure and Monitor

•• EHR ProgressEHR Progress•• MU MeasuresMU Measures

•• Consider Practice/HCO IssuesConsider Practice/HCO Issues


•• Security Risk AnalysisSecurity Risk Analysis•• Patient PortalPatient Portal•• Electronic TransactionsElectronic Transactions

MU Monitoring and DocumentingMU Monitoring and Documenting•• Monitor by EPMonitor by EP

•• At Least BiAt Least Bi--Weekly for 90 Days PeriodWeekly for 90 Days Period•• At Least Monthly OtherwiseAt Least Monthly Otherwise•• Increase Reviews as NeededIncrease Reviews as Needed

•• Document by EPDocument by EP•• Separate Package by EP for Each Period Separate Package by EP for Each Period (90 Day or Annual)(90 Day or Annual)•• Complete, Self Contained PackageComplete, Self Contained Package


•• Include Copy of Security Risk AnalysisInclude Copy of Security Risk Analysis




QUESTIONS AND ANSWERSQUESTIONS AND ANSWERS


RONALD B. STERLING, CPARONALD B. STERLING, CPASterling Solutions, Ltd.Sterling Solutions, Ltd.

RonaldRonald BB.. SterlingSterling publishespublishes thethe popularpopular EHREHR Blog,Blog, AvoidAvoid--EHREHR--DisastersDisasters..comcom andand authoredauthored thethe HIMSSHIMSS BookBook ofof thethe YearYear AwardAwardwinningwinning KeysKeys toto EHR/EHREHR/EHR SuccessSuccess -- SelectingSelecting andand ImplementingImplementing ananElectronicElectronic MedicalMedical RecordRecord RonRon isis aa nationallynationally recognizedrecognized thoughtthoughtElectronicElectronic MedicalMedical RecordRecord.. RonRon isis aa nationallynationally recognizedrecognized thoughtthoughtleaderleader onon thethe selection,selection, implementation,implementation, andand useuse ofof electronicelectronic healthhealthrecordrecord andand practicepractice managementmanagement systemssystems.. RonRon hashas advisedadvised healthcarehealthcareorganizationsorganizations andand practicespractices acrossacross thethe countrycountry.. RonRon hashas analyzedanalyzedsoftwaresoftware fromfrom overover 150150 vendorsvendors.. MrMr.. SterlingSterling hostshosts TheThe EHREHR ZoneZone ononHealthcareNOWRadioHealthcareNOWRadio..comcom andand hashas contributedcontributed articlesarticles toto aa widewide rangerangeofof publicationspublications includingincluding thethe widelywidely usedused MarketingMarketing YourYour ClinicalClinical PracticePractice..

AvoidAvoid--EHREHR--Disasters comDisasters com


AvoidAvoid EHREHR Disasters.comDisasters.comrbsterling@[email protected]

Office: (301)681Office: (301)681--42474247

stage 2 meaningful use: issues and strategies€¦ · meaningful use 1 at a glance •...

Documents